Assyro AI

FDA Orange Book · active-ingredient family

Caffeine citrate

Caffeine citrate is approved as 1 brand and 13 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CAFCIT · NDA 020793

1

Brand (NDA)

13

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
CAFCITRLD×2HIKMANDA 020793APSep 21, 1999

Generic (ANDA) products (13)

ProductApplicantApplicationTEApproved
CAFFEINE CITRATEMICRO LABSANDA 213202AADec 16, 2019
CAFFEINE CITRATEMICRO LABSANDA 207400APDec 14, 2017
CAFFEINE CITRATEEUGIA PHARMAANDA 205013Sep 22, 2015
CAFFEINE CITRATESAGENT PHARMSANDA 090827APAug 29, 2012
CAFFEINE CITRATESAGENT PHARMSANDA 091102AAAug 29, 2012
CAFFEINE CITRATEAM REGENTANDA 090064Nov 20, 2009
CAFFEINE CITRATESUN PHARMANDA 090077Sep 30, 2009
CAFFEINE CITRATESUN PHARMANDA 090357Sep 30, 2009
CAFFEINE CITRATEFRESENIUS KABI USAANDA 078002AAJan 31, 2008
CAFFEINE CITRATEFRESENIUS KABI USAANDA 077997APJul 20, 2007
CAFFEINE CITRATEAM REGENTANDA 077906APMay 15, 2007
CAFFEINE CITRATEEXELA PHARMA SCIENCEANDA 077233APSep 21, 2006
CAFFEINE CITRATEEXELA PHARMAANDA 077304AASep 21, 2006

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Caffeine citrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.